Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2014 | 1 |
2018 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19.
Lancet Oncol. 2018.
PMID: 30348538
Clinical Trial.
Standing in the GAP : To formulate a novel radioimmunotherapy regime to improve the long-term outcome in breast cancer.
Pock HL, Wei Bryan TY, Hoon TP, Iqbal J, Ching LY, Tee GY, Wai TK, Chong TH, Wee OK, Wei YK.
Pock HL, et al.
Immunotherapy. 2018 Feb 1;10(4):255-263. doi: 10.2217/imt-2017-0080.
Immunotherapy. 2018.
PMID: 29421981
Item in Clipboard
HEMATOPOIETIC STEM CELL TRANSPLANT IN AGGRESSIVE T AND NK/T CELL LYMPHOMA - ROLE OF UPFRONT AUTOLOGOUS TRANSPLANT IN NODAL PERIPHERAL T-CELL LYMPHOMA.
Cheng Kiat Ng L, Shwei Wen Tham C, Wei Inng Lim F, Chen Y, Yeu Ong S, Nagarajan C, Lee JJ, Tee Goh Y, Linn YC, Shan Lee Y, Diong Phipps C, Kim Siang Quek J, Hein T, Cheng Hwang JC, Grigoropoulos N, Khee Hwang WY, Yew Leng Ho A.
Cheng Kiat Ng L, et al. Among authors: tee goh y.
Blood Cell Ther. 2021 Nov 25;4(4):92-100. doi: 10.31547/bct-2021-007. eCollection 2021 Nov 25.
Blood Cell Ther. 2021.
PMID: 36714065
Free PMC article.
Item in Clipboard
Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma.
San-Miguel J, Bladé J, Shpilberg O, Grosicki S, Maloisel F, Min CK, Polo Zarzuela M, Robak T, Prasad SV, Tee Goh Y, Laubach J, Spencer A, Mateos MV, Palumbo A, Puchalski T, Reddy M, Uhlar C, Qin X, van de Velde H, Xie H, Orlowski RZ.
San-Miguel J, et al. Among authors: tee goh y.
Blood. 2014 Jun 26;123(26):4136-42. doi: 10.1182/blood-2013-12-546374. Epub 2014 May 15.
Blood. 2014.
PMID: 24833354
Free PMC article.
Clinical Trial.
Item in Clipboard
Autologous recovery with protractedly undetectable donor chimerisms can precede stable donor engraftment in a nonmyeloablative cord blood transplant.
Khee WH, Chye PT, Hoe TC, Fung HG, Khiang HK, Tee GY.
Khee WH, et al.
Int J Hematol. 2003 Jul;78(1):73-5. doi: 10.1007/BF02983244.
Int J Hematol. 2003.
PMID: 12894855
Item in Clipboard
Cite
Cite